The @EverBluCapital AM Report provides all-inclusive coverage on 430+ ASX listed companies & sectors, the latest market developments and company news. Written by our Research Team led by award winning analyst, Russell Wright. #Research #Markets
SIGN UP: https://t.co/UKXyiCRqqz
The @EverBluCapital Research Team initiates coverage on @CannPalAT. CPAT-01 is a drug at the forefront of a significant market opportunity worth more than US $1B p.a. #MedicalCannibis #Research #ASX #AnimalHealth
$CPH have signed a commercial agreement with Pharmacare Europe for the marketing + distribution of cannaQIX & other products in the UK. Pharmacare have over 10,000 points of sales in Europe alone #MedicalCannabis #CBD #UK #distribution @CresoPharma
EverBlu Capital's Video Channel
Videos produced by Finance News Network.
Access compelling results driven by a team of excellence
Are you interested in our services? Please feel free to contact us.